Vertex Pharmaceuticals (Australia) Pty Ltd

Regulatory activities for this sponsor.

2 result(s) found, displaying 1 to 2

AusPAR: Elexacaftor/tezacaftor/ivacaftor and ivacaftor

18 June 2021

Australian Public Assessment Report (AusPAR)

Australian Public Assessment Report for Elexacaftor/tezacaftor/ivacaftor and ivacaftor
Trikafta

8 April 2021

Prescription medicine decision summary

Australian prescription medicine decision summary